# Page 1
Under the NVHCP program, hepatitis B and hepatitis C rapid kits and medicines will be determined and purchased based on administrative approval.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-1221/ PR No. 04/ HEALTH-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
Date of release: March 31, 2022
(1) Government Resolution, Department of Public Health, No: PRASHAMA-1221/ PR No. 04/ Health-7, dated: 02.02.2021.
(2) Letter from Joint Director (Hospitals), Commissionerate of Health Services, Mumbai No: RAASO/ NVHCV/ Kits& Medicines/ Administrative Approval/ 122790/2022, dated: 03.03.2022.
(3) Note approved by the Commissioner Health Services and Mission Director, National Health Mission, Mumbai dated 15.02.2022.
(4) Letter of Government, Public Health Department, No: PRASHAMA-1221/ PR No. 04/ Arogya-7, dated: 09th March, 2022.
(5) Letter from Joint Director (Hospitals), Commissionerate of Health Services, Mumbai No: RASO/ NVHCV/ Kits& Medicines/ Administrative Approval/ 132623-626/2022, dated: 23.03.2022.
(6) Government Decision, Department of Public Health, No: Purchase-2016/ PR No. 240/ Health-8, dated: 26th July, 2017.
Preamble: In pursuance of the decision of the Government under Reference No. (1), the tender process for procurement of Rapid Kits for screening of Hepatitis B and Hepatitis C at 9 Model Treatment Centres (MTCs) and 27 Treatment Centres (TCs) under National Viral Hepatitis Control Programme in 35 districts of the State has been accorded administrative approval with a budget of Rs. 85.30 lakh under the project implementation plan PIP FMR Code 6.2.23.2 and PIP FMR Code 6.2.23.1 for the year 2020-21. Accordingly, the Joint Director (Hospitals), Commissionerate of Health Services, Mumbai vide letter No. 2 dated 2021-22, vide letter No.
# Page 2
Government Resolution No: PRASHAMA-1221/ PR No. 04/ HEALTH-7
Hepatitis B and C rapid kits and medicines under NVHCP programme for this financial year.
Based on the determination of the rate of injection, Rs.3,43,19,500/-and Rs. 3,75,35, 000/-
Administrative approval for estimated cost of procurement amounting to Rs. 7,18,54, 500/-
requested. Also, the proposal has been forwarded to the Commissioner Health Services and Mission Director, National
The Health Mission, Mumbai has given its approval as per note no.
However, the Commissionerate of Health Services, vide letter no. (4) under reference to Govt. of India, has notified that hepatitis B
Confirmation regarding the purchase of Rapid Kits and Medicines and Injections
was asked to do. In this regard, the Commissionerate of Health Services vide reference No. (5)
Haffkine Biopharmaceuticals Limited has decided to procure the subject matter under the letter
Based on price and availability. Commissioner of Health Services
Since the documents have been submitted to the Government, the subject matter proposal is subject to administrative approval
It was under the consideration of the government.
Government's decision:
National Viral Hepatitis as proposed by the Department of Health Services
Hepatitis B and C Rapid Kits for the year 2021-22 under NVHCP
Haffkine Biopharmaceuticals Corporation, Mumbai for procurement
Details of the proposed purchase are as follows:
" Details of the proposed purchase"
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Table I.. Rapid Kits Budget Requirement (Apporox.) |
| Sr. No.                                            | Name of Rapid Kit                          |             | Rate per Kit ( In Rs. ) | Quantity (No. of test/Kit) | Budget Required ( In Rs. ) | Total Budget Required for 2 Years ( In Rs. ) |
| 1st Year                                           | 2nd Year                                   | 1st Year    | 2nd Year                |
| 1                                                  | Hepatitis B Rapid Kit (Serum/Plasma bases) | 12          | 8,19,000                | 8,19,000                   |                            | 98,28,000                                    | 98,28,000 |           | 1,96,56,000 |
| 2                                                  | Hepatitis B Rapid Kt (Whole blood)         | 20          | 91,000                  | 91,000                     | 18,20,000                  | 18,20,000                                    | 36,40,000 |
| 3                                                  | Hepatitis B ELISA Kit (96 tests)           | 1,000       | 1,000 Kit               |                            | 1,000 Kit                  | 10,00,000                                    | 10,00,000 | 20,00,000 |
| 4                                                  | Hepatitis C Rapid Kit (Serum/Plasma bases) | 15          | 2,46,150                | 2,46,150                   | 36,24,750                  | 36,24,750                                    | 72,49,500 |
| 5                                                  | Hepatitis C Rapid Kit (Whole blood)        | 20          | 26,850                  | 26,850                     | 5,37,000                   | 5,37,000                                     | 10,74,000 |
| 6                                                  | Hapatitis C ELISA Kit (96 tests)           | 1,000       | 350 Kit                 | 350 Kit                    | 3,50,000                   | 3,50,000                                     | 7,00,000  |
| Total...                                           | 17159750                                   | 1,71,59,750 |                         | 3,43,19,500                |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Page 2 of 6
# Page 3
Government Resolution No: PRASHAMA-1221/ PR No. 04/ HEALTH-7
Haffkine Biopharmaceuticals to procure Rapid Kits for Hepatitis B and C
As determined by the Corporation, it is available under the heading" PIP FMR Code 6.2.23.2"
Rs. 3,43,19, 500/- (Rupees Three Crores Thirty Three Lakhs Nineteen Thousand Five Hundred only)
Administrative approval is being given to the proposed estimated cost.
Also, under the NVHCP program as per the proposal submitted by the Commissionerate of Health Services
Haffkine Biopharma to procure Hepatitis B and C drugs and injections for 2021-22
Details of the proposed procurement as estimated by the Construction Corporation, Mumbai
It is as follows:
" Details of the proposed purchase"
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Table II.. NVHCP Medicine Budget Requirement (Apporox.) |
| Sr. No.                                                 | Name of Medicine                                       | Rate per Tab/ Inj ( In Rs.) | Quantity  | Budget Required ( In Rs.) | Total Budget Required for 2 Years ( In Rs. ) |
| 1st Year                                                | 2nd Year                                               | 1st Year                    | 2nd Year  |
| Hepatitis B Medicine                                    |
| 1                                                       |                                                        | Tab Entecavir (Ent 0.5mg )  | 11        | 40,000                    | 40,000                                       | 4,40,000    | 4,40,000    | 8,80,000  |
| 2                                                       |                                                        | Tab Entercavie (Ent 1mg )   | 13        | 10,000                    | 10,000                                       | 1,30,000    | 1,30,000    | 2,60,000  |
| 3                                                       | Tab Tenofovir 300 mg                                   | 7                           | 40,000    | 40,000                    | 2,80,000                                     | 2,80,000    | 5,60,000    |
| Hepatitis C Medicine                                    |
| 4                                                       | Tab Daclatasvir 30 mg                                  | 9                           | 9,000     | 9,000                     | 81,000                                       | 81,000      | 1,62,000    |
| 5                                                       | Tab Daclatasvir 60mg                                   | 9                           | 13,500    | 13,500                    | 1,21,500                                     | 1,21,500    | 2,43,000    |
| 6                                                       | Tab Sofosbuvir 400 mg                                  | 22                          | 9,000     | 9,000                     | 1,98,000                                     | 1,98,000    | 3,96,000    |
| 7                                                       | Tab Sofosbuvir 400 mg + Velpatasvir 100 mg             | 75                          | 54,000    | 54,000                    | 40,50,000                                    | 40,50,000   |             | 81,00,000 |
| 8                                                       | Tab Ribavirin 200 mg for Hepatitis C complicated cases | 6                           | 4,500     | 4,500                     | 27,000                                       | 27,000      | 54,000      |
| Prophylaxis                                             |
| 9                                                       | Inj HBIG                                               | 1,920                       | 7,000     | 7,000                     | 1,34,40,000                                  | 1,34,40,000 | 2,68,80,000 |
| Total...                                                | 1,87,67,500                                            | 1,87,67,500                 |           | 3,75,35,000               |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Haffkine Biopharma for purchase of Hepatitis B and C drugs and injections
As determined by the Construction Corporation under the head" PIP FMR Code 6.2.23.1"
Rs. 3,75,35, 000/- (Rupees Three Crores Seventy Five Lakhs Thirty Five Thousand only) out of the available subsidy.
Administrative approval is being given to the proposed estimated cost.
In this case, Hepatitis B and Hepatitis C will be covered under the NVHCP programme for the financial year 2021-22
Rs. 3,43,19, 500/- (Rupees Three only) for purchase of Rapid Kits and Medicines and Injections respectively.
Thirty Three Lakhs Nineteen Thousand Five Hundred only) and Rs. 3,75,35, 000/- (Rupees Three Crores)
Page 3 of 6
# Page 4
Government Resolution No: PRASHAMA-1221/ PR No. 04/ HEALTH-7
The proposed expenditure estimated at Rs. 7,18,54, 500/- (Rupees Seven Crores Eighteen Lakhs Fifty Four Thousand Five Hundred only) is being accorded administrative approval subject to the following terms and conditions:
(1) The requirement/ demand for the purchase of these rapid kits, medicines and injections should be verified. Thereafter, the tender process will be initiated.
(2) It should be ensured that the specifications of such rapid kits, medicines and injection materials are as per the requirement and up-to-date. The technical specifications of the items to be procured should be as per the specifications agreed by the concerned experts (Technical Committee/ Officials).
(3) It shall be ensured that the technical specifications of the items to be procured are not prepared in a manner which is likely to benefit any particular company.
In this regard, it will be the responsibility of the concerned programme head to send the requisition as per the technical specifications of the items approved in the PIP and to procure the items included in the proposal.
(4) The prescribed procurement procedure should be carried out in accordance with the provisions of the revised rule book of procedures for office procurement to be carried out by government departments published under the Government Decision, Industry, Energy and Labor Department, No. 2014/ PR No. 82/ Part-III/ Industry-4, dated December 1, 2016.
(5) The rates of the proposed purchases are estimated at the time of granting administrative approval. Therefore, the price should be determined at the end of the purchase process. The price is lower than the market price
It should be ensured that the supplier does not exceed the rate at which the item is supplied elsewhere.
(6) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only the items with proper and correct specifications are purchased.
(7) Storage and distribution of the items to be procured and supply chain management; and
Page 4 of 6
# Page 5
Government Resolution No: PRASHAMA-1221/ PR No. 04/ HEALTH-7
The inventory management should be done in a proper manner to ensure that these items do not remain unused and they are used within the stipulated time.
(8) The cost for the said procurement shall be met from the grants-in-aid sanctioned under the head PIP FMR Code 6.2.23.2 and PIP FMR Code 6.2.23.1 of the Project Implementation Plan 2021-22. Also, it should be ensured that the purchase is completed within the prescribed period of administrative approval.
(9) Also, it should be ensured that there is no duplication in the purchase of these items.
The Central Vigilance Commission (CVC) guidelines should be strictly followed while implementing the entire procurement process.
30/ Part- 2/2013/ Regulations, dated 17th April, 2015 in Annexure A to Rule No.4 of the Financial Powers Rules, 1978, Part-I Sub-Section-II. 7 in front of No. 6 conditions must be met.
(12) Supply orders shall be issued only after the approval of the Procurement Committee after the completion of the procurement process.
(13) After completion of the process, supply orders shall be issued only after approval of the Purchase Committee. Further, action in the matter should be taken in accordance with the provisions of the Government Resolution, Public Health Department, No: Purchase 2016/ PR No. 240/ Health-8, dated 26th July, 2017.
The Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai, Director (Health Services), Directorate of Health Services, Mumbai and the Programme Head shall be solely responsible for ensuring that the conditions and conditions mentioned in the above Annexure (1) to (13) are fulfilled and the procurement is as per the rules and requirements.
Government Resolution, Department of Finance, vide No. 2013/ P.S. 30/13/ Regulations, Part-II, dated 17th April, 2015 in the Financial Powers Rules, 1978 Part-I, Sub-Section-II, Section 4, Rule No. Under Section 7, full powers have been delegated to the administrative department to approve the purchase of implements, spare parts and activity kits. Accordingly, the government has taken the decision.
Page 6 of 5
# Page 6
Government Resolution No: PRASHAMA-1221/ PR No. 04/ HEALTH-7